We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Transcriptome Selection Reveals Tumor Genes

By Biotechdaily staff writers
Posted on 06 Aug 2003
Researchers have identified 57 genes linked to the growth of human tumor cells. More...
These genes were pinpointed as a result of transcriptome-scale selection, which was used to isolate genetic suppressor elements (GSEs) inhibiting breast carcinoma cell growth.

The information buried in the genome of an organism is extracted by the process of transcription in which the DNA sequence of a gene is transcribed into the sequence of a messenger RNA (mRNA). The primary steps of this process are mRNA initiation, elongation, and termination. These are coupled to a huge network of post-transcriptional events that mature the mRNA into a form that can be exported from the nucleus to the cytoplasm, where it will be translated into the protein product. The whole process of transcription from initiation to export from the nucleus is highly regulated to ensure the gene products are present only at a specific time or place, for example, at a particular stage of development or in a specific tissue. The corresponding body of transcripts present at any given moment is called the transcriptome.

The strategy employed by investigators at the University of Illinois at Chicago (UIC, USA), described in the July 22, 2003, issue of Cancer Cell, required cutting human DNA into tiny, random fragments; inserting the fragments into a mammalian cell using a vector; and inducing the fragments to express their genetic information. Some of the fragments proved to be biologically active by interfering with the function of the genes from which they were derived.

"Our strategy was validated by the fact that more than half of the genes we identified were already known to play key roles in the growth of cells or the development of cancers,” explained senior author Dr. Igor Roninson, professor of molecular genetics at the University of Illinois. "Many of the other genes, however, were not previously known to be involved in cell division and proliferation. In fact, the functions of some of these genes were entirely unknown. The genes we have identified clearly have the potential to serve as targets for novel therapeutics in the fight against cancer.”



Related Links:
University of Illinois

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Urine Analyzer
respons® UDS100
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.